Pharmacosmos Therapeutics, an affiliate of Denmark based Pharmacosmos, has launched Monoferric® in
the rapidly growing US high-dose IV iron market. We’ve established a culture with the shared purpose of
establishing a new standard of care for IV iron patients. Pharmacosmos Therapeutics brings together a
best-in-class product, the resources required to drive rapid growth, and an experienced, high-performing
team that is recognized and rewarded for their efforts to drive the business.
